Insight

Adjuvant Endocrine Therapy Adherence in patients with breast cancer – Dana-Farber’s Breast Oncology Center

Photo taken from Kelcie D Willis/X

Sep 10, 2024, 14:58

Adjuvant Endocrine Therapy Adherence in patients with breast cancer – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“New: Effects of Adjuvant Endocrine Therapy-Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer.”

Effects of Adjuvant Endocrine Therapy-Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer

Authors: Kelcie D Willis, Emily A Walsh, Laura E Dunderdale, Kathryn Post, Nora Horick^, Michael H Antoni^, Steven A Safren, Ann H Partridge, Jeffrey Peppercorn, Elyse R Park, Jennifer S Temel, Joseph A Greer, Jamie M Jacobs

Adjuvant Endocrine Therapy Adherence in patients with breast cancer - Dana-Farber’s Breast Oncology Center

Source: Dana-Farber’s Breast Oncology Center/X

adjuvant endocrine therapy Ann H. Partridge Behavioral Intervention Breast Cancer cancer Dana-Farber’s Breast Oncology Center Elyse R. Park Emily A Walsh Jamie M Jacobs Jeffrey Peppercorn Jennifer S Temel Joseph A Greer Kathryn Post Kelcie D. Willis Laura E Dunderdale Michael H Antoni Nora Horick OncoDaily Oncology Steven A Safren

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage